Natco Pharma Ltd on Thursday said it has received an establishment inspection report from the US health regulator for its Kothur unit in Hyderabad, classifying the facility as ‘voluntary action indicated’. The US Food and Drug Administration (FDA) had conducted an inspection at the company’s pharma division located in Kothur, Hyderabad, Natco Pharma said in…
Natco Pharma gets USFDA EIR for Kothur Pharma division We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk, maker of blockbuster weight-loss drug Wegovy (semaglutide), claiming its version of the drug does not infringe upon the device or process patent technology owned by the multinational company. The case came up for hearing in Delhi High Court on Wednesday. “The court has directed the…
Natco Pharma on Wednesday said it has launched a generic medication to treat high blood pressure in the lungs in the US with 180-day exclusivity. The company has launched Bosentan tablets for oral suspension (32 mg), a generic version of Tracleer tablets by Actelion Pharmaceuticals US Inc. Natco’s marketing partner for the product is Lupin…
Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link